echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Gut: Existing imaging methods are still not effective in screening for pancreatic cancer in time!

    Gut: Existing imaging methods are still not effective in screening for pancreatic cancer in time!

    • Last Update: 2021-04-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pancreatic cancer is a kind of cancer with a high fatality rate.


    Pancreatic cancer screening

    This study aims to evaluate the long-term benefits of pancreatic cancer surveillance in high-risk genetically susceptible populations.


    This study aims to evaluate the long-term benefits of pancreatic cancer surveillance in high-risk genetically susceptible populations.


    From 2006 to 2019, researchers retrospectively recruited asymptomatic individuals with an estimated lifetime risk of pancreatic ductal adenocarcinoma (PDAC) ≥10%.


    In total, 366 individuals were recruited, including 201 non-mutant relatives of familial pancreatic cancer (FPC) patients and 165 PDAC susceptible gene mutation carriers .


    A total of 366 individuals were recruited, including 201 non-mutant relatives of familial pancreatic cancer (FPC) patients and 165 PDAC susceptible gene mutation carriers

    Cumulative incidence of pancreatic cancer

    Cumulative incidence of pancreatic cancer

    Ten individuals suffered from PDAC, four of whom were symptomatic septal carcinoma, and six were successfully surgically removed.


    The cumulative incidence of PDAC in mutation carriers is 9.


    Sensitivity to detect pancreatic lesions

    Sensitivity to detect pancreatic lesions

    17 (4.


    17 (4.


    In summary, for known carriers of high-risk mutations, regular follow-up PDAC diagnosis rate is relatively high, but no PDAC was found in FPC relatives who do not carry the mutation.


    The diagnostic effect produced by imaging means is not good.


    Original source:

    Overbeek KA, Levink IJM, Koopmann BDM, et al Long-term yield of pancreatic cancer surveillance in high-risk individuals Gut Published Online First: 05 April 2021.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.